BTF3 Antibodies

Santa Cruz Biotechnology provides a broad selection of BTF3 monoclonal antibodies for research focused on understanding Basic Transcription Factor 3 (BTF3). BTF3 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BTF3 serves as a crucial component in the regulation of gene expression, playing a significant role in the transcriptional machinery of cells. BTF3 actively participates in the recruitment of RNA polymerase II to promoters, thereby influencing the initiation of transcription. Understanding BTF3 functionality is essential for elucidating the mechanisms of gene regulation and its implications in various biological processes and diseases. BTF3 has been identified as a potential biomarker in several cancer types, making it an important target for oncology research. Recent studies have highlighted BTF3's involvement in cell cycle regulation and apoptosis, expanding its significance in cellular biology. BTF3 research continues to reveal new insights into transcriptional control mechanisms and cellular homeostasis. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of BTF3's role in health and disease.